[{"question": "Activated macrophages secrete:", "correct_answer": "interleukin-4", "correct_idx": 2, "options": ["A)interleukin-2", "B)L-2)", "C)interleukin-4", "D)L-4)"], "prompt": "Activated macrophages secrete:A)interleukin-2\nB)L-2)\nC)interleukin-4\nD)L-4)", "subject_name": null, "output0": "Activated macrophages secrete interleukin-2 (IL-2), which is a cytokine that helps to activate and regulate the immune response.\n\n", "output1": "Activated macrophages secrete L-2, which is a cytokine that helps to regulate the immune response.\n\n", "output2": "Activated macrophages secrete interleukin-4 (IL-4), which is a cytokine that plays a role in the regulation of the immune response and the development of allergies.\n\n", "output3": "Activated macrophages secrete L-4, a cytokine that plays a role in the regulation of the immune response.\n\n"}, {"question": "About syphilis narrative Which statement is correct?", "correct_answer": "Secondary syphilis rash typically occurs in 3 to 12 weeks after the chancre appears, but the time may occur in HIV patients overlap and chancre", "correct_idx": 2, "options": ["A)Treponema (Treponema pallidum) may be utilized with other microscopic nonvenereal diseases differential diagnosis of treponemes", "B)After two treated syphilis rash, rash usually fade 4 to 12 weeks", "C)Secondary syphilis rash typically occurs in 3 to 12 weeks after the chancre appears, but the time may occur in HIV patients overlap and chancre", "D)Blood-specific treponemal test is the best indicator to monitor the effect of treatment of syphilis"], "prompt": "About syphilis narrative Which statement is correct?A)Treponema (Treponema pallidum) may be utilized with other microscopic nonvenereal diseases differential diagnosis of treponemes\nB)After two treated syphilis rash, rash usually fade 4 to 12 weeks\nC)Secondary syphilis rash typically occurs in 3 to 12 weeks after the chancre appears, but the time may occur in HIV patients overlap and chancre\nD)Blood-specific treponemal test is the best indicator to monitor the effect of treatment of syphilis", "subject_name": null, "output0": "The statement is correct because Treponema pallidum, the bacterium that causes syphilis, can be differentiated from other microscopic nonvenereal diseases using the Turtle Technique.\n\n", "output1": "After two treated syphilis rash, the rash usually fades within 4 to 12 weeks. This is because the antibiotics used to treat syphilis are effective in killing the bacteria that cause the rash, and the body's immune system is able to clear the infection.\n\n", "output2": "The correct answer is C)Secondary syphilis rash typically occurs in 3 to 12 weeks after the chancre appears, but the time may occur in HIV patients overlap and chancre. This is because secondary syphilis rash typically develops 3 to 12 weeks after the chancre appears, but in HIV patients, the rash may overlap with the chancre.\n\n", "output3": "The blood-specific treponemal test is the most reliable indicator of the effectiveness of syphilis treatment. It measures the presence of antibodies against Treponema pallidum, the bacteria that causes syphilis, in the blood. This test is more accurate than other diagnostic tests, such as the rapid plasma reagin (RPR) test, which measures the presence of antibodies against Treponema pallidum in the blood.\n\n"}, {"question": "CA-125 is a marker for the screening of ovarian cancer. To characterize this test, histopathological confirmation of ovarian cancer was done in a coho of patients. 60/100 women who tested positive for this test had ovarian cancer and 20/100 women who tested negative had ovarian cancer. What is the negative predictive value of this test?", "correct_answer": "80/100", "correct_idx": 3, "options": ["A)20/100", "B)40/100", "C)60/100", "D)80/100"], "prompt": "CA-125 is a marker for the screening of ovarian cancer. To characterize this test, histopathological confirmation of ovarian cancer was done in a coho of patients. 60/100 women who tested positive for this test had ovarian cancer and 20/100 women who tested negative had ovarian cancer. What is the negative predictive value of this test?A)20/100\nB)40/100\nC)60/100\nD)80/100", "subject_name": "Social & Preventive Medicine", "output0": "The negative predictive value of a test is the proportion of people who test negative and do not have the disease. In this case, the test is CA-125, and the disease is ovarian cancer. The negative predictive value is calculated as follows:\n\n", "output1": "The negative predictive value of a test is the proportion of patients who test negative and do not have the disease. In this case, 40/100 women who tested negative for CA-125 did not have ovarian cancer.\n\n", "output2": "The negative predictive value of a test is the proportion of people who test negative and do not have the disease. In this case, the test is CA-125, and the disease is ovarian cancer. Of the 100 women who tested negative for CA-125, 20 actually had ovarian cancer. Therefore, the negative predictive value of this test is 60/100, or 60%.\n\n", "output3": "The negative predictive value of a test is the proportion of individuals who test negative and do not have the disease. In this case, the test is CA-125, and the disease is ovarian cancer.\n\n"}, {"question": "The ratio between the incidence of disease among exposed and non-exposed is called:", "correct_answer": "Relative risk", "correct_idx": 1, "options": ["A)Causal risk", "B)Relative risk", "C)Attributable risk", "D)Odds ratio"], "prompt": "The ratio between the incidence of disease among exposed and non-exposed is called:A)Causal risk\nB)Relative risk\nC)Attributable risk\nD)Odds ratio", "subject_name": "Dental", "output0": "The causal risk is the ratio of the incidence of disease among exposed individuals to the incidence of disease among non-exposed individuals. It is a measure of the strength of the relationship between exposure and disease.\n\n", "output1": "The relative risk is a measure of the ratio between the incidence of disease among exposed and non-exposed individuals. It is calculated as the ratio of the incidence of disease in the exposed group to the incidence of disease in the non-exposed group.\n\n", "output2": "Attributable risk is the proportion of disease that can be attributed to a specific exposure or risk factor, taking into account both the incidence of the disease and the prevalence of the exposure. It is calculated as the difference between the incidence of disease in the exposed group and the incidence of disease in the non-exposed group, divided by the prevalence of the exposure.\n\n", "output3": "The odds ratio is the ratio of the incidence of disease among exposed individuals to the incidence of disease among non-exposed individuals. It is a measure of the relative risk of disease associated with exposure to a particular factor or factor.\n\n"}, {"question": "What drug is indicated in the treatment of chronic myeloid leukemia ?:", "correct_answer": "Imatinib", "correct_idx": 2, "options": ["A)Toremifene.", "B)Cetuximab.", "C)Imatinib", "D)Rituximab"], "prompt": "What drug is indicated in the treatment of chronic myeloid leukemia ?:A)Toremifene.\nB)Cetuximab.\nC)Imatinib\nD)Rituximab", "subject_name": "pharmacology", "output0": "The correct answer is A)Toremifene. Toremifene is a drug that is indicated in the treatment of chronic myeloid leukemia. It works by inhibiting the growth of cancer cells and is often used in combination with other treatments.\n\n", "output1": "Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), which is overexpressed in many types of cancer, including chronic myeloid leukemia (CML). It is used to treat patients with CML who have failed other treatments or who cannot tolerate other treatments.\n\n", "output2": "Imatinib is a tyrosine kinase inhibitor that is specifically indicated for the treatment of chronic myeloid leukemia (CML). It works by inhibiting the activity of the Bcr-Abl fusion protein, which is a characteristic feature of CML. Imatinib is often used as a first-line treatment for CML and has been shown to be effective in reducing the number of cancer cells and improving patient survival.\n\n", "output3": "Rituximab is a monoclonal antibody that is used to treat chronic myeloid leukemia. It works by targeting and destroying cancer cells, and is often used in combination with other chemotherapy drugs.\n\n"}, {"question": "Diluent used in BisGMA based composites:", "correct_answer": "TEGDMA", "correct_idx": 1, "options": ["A)4META", "B)TEGDMA", "C)UDMA", "D)CDMA"], "prompt": "Diluent used in BisGMA based composites:A)4META\nB)TEGDMA\nC)UDMA\nD)CDMA", "subject_name": "Dental", "output0": "4META is the most commonly used diluent in BisGMA based composites. It is a low viscosity monomer that is compatible with BisGMA and helps to improve the handling properties of the composite.\n\n", "output1": "TEGDMA is a common diluent used in BisGMA based composites. It is a polymer that helps to improve the flow and wetting properties of the composite, making it easier to apply and manipulate.\n\n", "output2": "UDMA is a common diluent used in BisGMA-based composites. It is a relatively slow-setting material that allows for better control over the setting time and is less likely to cause shrinkage or other defects.\n\n", "output3": "CDMA is the most commonly used diluent in BisGMA based composites. It has a high viscosity and is less reactive than other diluents, such as TEGDMA, which makes it easier to handle and mix. Additionally, CDMA has a lower shrinkage rate, which can help reduce the risk of shrinkage stress and improve the overall performance of the composite.\n\n"}, {"question": "Deficiency of enzyme aromatase leads to deficiency of which hormone ?", "correct_answer": "Estrogen", "correct_idx": 1, "options": ["A)Coisol", "B)Estrogen", "C)Testosteron", "D)Mineral coicoids"], "prompt": "Deficiency of enzyme aromatase leads to deficiency of which hormone ?A)Coisol\nB)Estrogen\nC)Testosteron\nD)Mineral coicoids", "subject_name": "Physiology", "output0": "Deficiency of aromatase leads to deficiency of estrogen.\n\n", "output1": "Deficiency of aromatase enzyme leads to deficiency of estrogen hormone. Aromatase enzyme is responsible for converting androgens to estrogens.\n\n", "output2": "Deficiency of aromatase leads to deficiency of testosterone. Aromatase is an enzyme that converts testosterone into estrogen. Without aromatase, testosterone cannot be converted into estrogen, leading to a deficiency of testosterone.\n\n", "output3": "Deficiency of aromatase leads to deficiency of estrogen, which is the hormone that is produced by aromatization. Mineral coicoids are not affected by aromatase deficiency.\n\n"}, {"question": "A 3-year-old male is brought in to his pediatrician by his mother because she is concerned that he is not growing appropriately. Physical examination is notable for frontal bossing and shortened upper and lower extremities. His axial skeleton appears normal. He is at the 7th percentile for height and 95th percentile for head circumference. He demonstrates normal intelligence and is able to speak in three-word sentences. He first sat up without support at twelve months and started walking at 24 months. Genetic analysis reveals an activating mutation in a growth factor receptor. Which of the following physiologic processes is most likely disrupted in this patient\u2019s condition?", "correct_answer": "Endochondral ossification", "correct_idx": 2, "options": ["A)Intramembranous ossification", "B)Osteoblast maturation", "C)Endochondral ossification", "D)Production of type I collagen"], "prompt": "A 3-year-old male is brought in to his pediatrician by his mother because she is concerned that he is not growing appropriately. Physical examination is notable for frontal bossing and shortened upper and lower extremities. His axial skeleton appears normal. He is at the 7th percentile for height and 95th percentile for head circumference. He demonstrates normal intelligence and is able to speak in three-word sentences. He first sat up without support at twelve months and started walking at 24 months. Genetic analysis reveals an activating mutation in a growth factor receptor. Which of the following physiologic processes is most likely disrupted in this patient\u2019s condition?A)Intramembranous ossification\nB)Osteoblast maturation\nC)Endochondral ossification\nD)Production of type I collagen", "subject_name": null, "output0": "The patient's physical examination findings of frontal bossing and shortened upper and lower extremities suggest a disruption in intramembranous ossification, which is the process by which bones form directly from mesenchymal cells without the intermediate step of cartilage. The patient's genetic analysis showing an activating mutation in a growth factor receptor also supports this diagnosis.\n\n", "output1": "The patient is presenting with frontal bossing, shortened upper and lower extremities, and a short stature, which are all characteristic of a condition known as dwarfism. Dwarfism is caused by a disruption in the physiologic process of osteoblast maturation, which is the process by which osteoblasts, the cells responsible for bone formation, mature and differentiate into bone tissue. The patient's genetic mutation in a growth factor receptor is likely disrupting this process, leading to the characteristic features of dwarfism.\n\n", "output2": "Endochondral ossification is the process by which cartilage is replaced by bone. Disruption of this process can result in shortened limbs, as seen in this patient. The other options are not directly related to the patient's symptoms.\n\n", "output3": "The patient's symptoms of frontal bossing and shortened upper and lower extremities suggest a disruption in the production of type I collagen. Type I collagen is a critical component of bone and is responsible for its strength and integrity. An activating mutation in a growth factor receptor can lead to an overproduction of type I collagen, which can result in the symptoms seen in this patient.\n\n"}, {"question": "Zirconia stabilized with calcium oxide:", "correct_answer": "It has a huge defect in oxygen population.", "correct_idx": 1, "options": ["A)It has a huge excess in oxygen population.", "B)It has a huge defect in oxygen population.", "C)The oxygen population is the same as in zirconia without calcium oxide.", "D)There is no relationship between the presence of calcium and the oxygen population."], "prompt": "Zirconia stabilized with calcium oxide:A)It has a huge excess in oxygen population.\nB)It has a huge defect in oxygen population.\nC)The oxygen population is the same as in zirconia without calcium oxide.\nD)There is no relationship between the presence of calcium and the oxygen population.", "subject_name": "chemistry", "output0": "When calcium oxide is added to zirconia, it forms a defect in the crystal structure that results in an excess of oxygen vacancies. This excess of oxygen vacancies can lead to a higher concentration of oxygen in the material, which can affect its properties and behavior.\n\n", "output1": "When zirconia is stabilized with calcium oxide, it has a huge defect in oxygen population because the calcium ions substitute for some of the oxygen ions in the zirconia lattice, creating a defect in the material.\n\n", "output2": "The presence of calcium oxide in zirconia does not affect the oxygen population. The oxygen vacancies are stabilized by the calcium ions, which do not introduce new defects or alter the existing ones.\n\n", "output3": "The presence of calcium oxide in zirconia does not affect the oxygen population. Calcium oxide is used to stabilize the zirconia and improve its mechanical properties, but it does not alter the oxygen content of the material.\n\n"}, {"question": "Investigation of choice for a lesion of the temporal bone is", "correct_answer": "CT", "correct_idx": 2, "options": ["A)X-ray", "B)USG", "C)CT", "D)MRI"], "prompt": "Investigation of choice for a lesion of the temporal bone isA)X-ray\nB)USG\nC)CT\nD)MRI", "subject_name": "Radiology", "output0": "X-ray is the investigation of choice for a lesion of the temporal bone because it can provide clear images of the bony structures and can help to identify any fractures or other abnormalities in the bone.\n\n", "output1": "Ultrasound (USG) is the investigation of choice for a lesion of the temporal bone because it provides a non-invasive and cost-effective way to evaluate the bone and its surrounding soft tissues. Additionally, USG can help identify the presence of fluid or blood in the bone, which can be an important diagnostic clue in the evaluation of temporal bone lesions.\n\n", "output2": "CT scans are the best method for evaluating bony structures and lesions of the temporal bone, as they provide high-resolution images and can help to identify small details that may be missed on other imaging modalities, such as X-rays or MRI.\n\n", "output3": "Magnetic Resonance Imaging (MRI) is the most appropriate investigation for a lesion of the temporal bone, as it provides high-resolution images of the brain and can detect even small lesions that may not be visible on other imaging techniques.\n\n"}]